My Policy Advocate Launches Nationwide to Help Americans Understand Their Insurance Policies with AI-Powered, Human-Centered SupportNew York, NY, Nov. 15, 2025 (GLOBE NEWSWIRE) -- My Policy Advocate (MPA), a pioneering independent insurance support platform, has officially launched across all 50 states, offering a powerful new solution to one of the most persistent challenges in personal finance – understanding insurance. The service offers plain-language policy analysis, secure document management, 24/7 live support, and expert guidance, entirely free from insurer influence or sale commissions.
Thurgood Marshall College Fund supports turkey, clothing and gas giveaway for ThanksgivingWashington, D.C., Nov. 15, 2025 (GLOBE NEWSWIRE) -- The Thurgood Marshall College Fund (TMCF) is serving as a sponsor of the New Testament Gospel Worldwide Ministries (NTG) 7th-annual turkey, clothing and gas giveaway on Nov. 22 in Rex, Georgia.
Purdue and Google aim to grow a strategic AI partnershipMung Chiang and Karen Dahut speak about AI research and AI in education at 2025 Google-Purdue AI Summit
Mantiqueira USA Announces Acquisition of Hickman’s Egg Ranch, Marking U.S. ExpansionGREELEY, Colo., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Mantiqueira USA (MTQ USA) today announced it has entered a binding agreement to acquire Hickman’s Egg Ranch, a leading egg producer based in the Mountain and West Coast regions and ranked among the top 20 egg companies in the United States. The acquisition marks a significant milestone in MTQ USA’s launch and its long-term strategy to build a strong, scalable presence in the U.S. egg market.
BAX INVESTORS: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Baxter International, Inc.NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Baxter International, Inc. (“Baxter” or the “Company”) (
NYSE:BAX) investors of the December 15, 2025 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Baxter securities between February 23, 2022 through July 30, 2025 (“the Class Period”).
IO DeFi Redefines DeFi Stability in 2025 with Innovative Yield Contracts and Renewable-Powered Blockchain NetworkIn a year defined by volatility and market uncertainty, IO DeFi has emerged as a rare symbol of stability and innovation in the global crypto space. Today, the company officially announces the global launch of its advanced decentralized finance platform — a next-generation system designed to deliver automated, transparent, and sustainable daily income for users worldwide.
Dynamix Corporation III Announces the Separate Trading of its Class A ordinary shares and Warrants Commencing November 19, 2025Houston, TX, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Dynamix Corporation III (the “Company”) today announced that commencing November 19, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units. Class A ordinary shares and warrants that are separated will trade on the Nasdaq Stock Market LLC under the ticker symbol “DNMX” and “DNMXW,” respectively. Those units not separated will continue to trade on the Nasdaq Stock Market LLC under the symbol “DNMXU.” No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Odyssey Transfer and Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.
Viking Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing November 20, 2025NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Viking Acquisition Corp. I (NYSE: VACI.U) (“Company”) announced today that holders of the Company’s public units may elect to separately trade the Class A ordinary shares and warrants underlying such public units commencing on November 20, 2025. Each unit consists of one Class A ordinary share and one third of one redeemable warrant of the Company. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilitiesNEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (
NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it had sold its rights to the “Obagi” trademark in Japan to Rohto Pharmaceutical Co., Ltd. (“Rohto”) for USD $82.5 million.
Rivalry Extends Closing Date for Non-Brokered Private PlacementTORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Rivalry Corp. (the "Company" or "Rivalry") (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the leading sportsbook and iGaming operator for digital-first players, is extending the closing date for the final tranche of its non-brokered private placement (the "Private Placement") previously announced on September 29, 2025, for an additional 30 days.
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial ResultsData from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrolimus
Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business UpdateROCHESTER, NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today announced it will host a conference call to discuss its financial results and provide a business update on Tuesday, November 18, 2025, at 5:00 p.m. Eastern Time (ET).
FRO – Notice of Annual General Meeting 2025Frontline plc (the “Company”) announces that its 2025 Annual General Meeting will be held on December 8, 2025. A copy of the Notice of Annual General Meeting and associated information including the Company’s Annual Report on Form 20-F for 2024 can be found on our website at www.frontlineplc.cy and attached to this press release.
BGIN BLOCKCHAIN LIMITED Reports Unaudited Financial Results for the Six Months Ended June 30, 2025SINGAPORE, Nov. 15, 2025 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (“BGIN” or the “Company”; NASDAQ: BGIN), a digital asset technology company with proprietary cryptocurrency mining technologies and an innovator in cryptocurrency mining hardware and infrastructure, today released its unaudited financial results for the six months ended June 30, 2025 (“1H 2025”).
Health Catalyst to Participate in Upcoming Investor ConferencesSALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:
Banzai Reports Third Quarter 2025 Financial ResultsRevenue of $2.8 Million for Q3 2025, up 163% from Q3 2024
Insight Digital Partners II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about November 18, 2025NEW YORK, NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Insight Digital Partners II (Nasdaq: DYORU) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the exercise by the underwriters of their overallotment option in full, completed on October 30, 2025 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about November 18, 2025. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “DYORU,” and each of the Class A ordinary shares and warrants will separately trade on The Nasdaq Global Market under the symbols “DYOR” and “DYORW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on November 12, 2025 (the “Grant Date”), the Company’s Board of Directors granted a non-qualified stock option to purchase 80,000 shares of the Company’s common stock to a newly hired employee of the Company as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
Capital Bancorp Appoints Jacob Dalaya as Chief Financial OfficerROCKVILLE, Md., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Capital Bancorp, Inc. (
NASDAQ: CBNK) today announced the appointment of Jacob Dalaya as Executive Vice President and Chief Financial Officer of Capital Bancorp and Capital Bank, National Association, effective immediately.
Gemini to Participate in Citi’s 14th Annual FinTech ConferenceNEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Gemini Space Station, Inc. (Gemini) (
NASDAQ: GEMI) today announced that Marshall Beard, Chief Operating Officer, and Dan Chen, Chief Financial Officer, will attend Citi’s 14th Annual FinTech Conference on November 18, 2025. Management will be available for one-on-one and small group investor meetings.
Strive, Inc. Announces Third Quarter 2025 Financial ResultsDALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST) (“Strive” or the “Company”), the first Bitcoin treasury company amplified exclusively with perpetual preferred equity, today announced its financial results for the third quarter ended September 30, 2025.
Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in LondonFOSTER CITY, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be presenting at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:30 p.m. GMT.
Epsilon Announces the Closing of the Acquisitions of the Peak Companies With Assets in the Powder River BasinHOUSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (
NASDAQ: EPSN) today reported the consummation of the previously announced acquisitions of Peak Exploration and Production LLC and Peak BLM Lease LLC (together, the “Peak Companies”) (the “Closing”).
Biogen Completes Acquisition of Alcyone TherapeuticsCAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such as the ThecaFlex DRx™ drug delivery system.
Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results– Company reports $14.3 million in revenue in Q3’25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license and collaboration revenue –
4DMT Announces New Employment Inducement GrantsEMERYVILLE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on November 11, 2025, the compensation committee of the Company’s board of directors granted four new non-executive employees 45,400 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, which was approved by the Company’s board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.
Coherent Introduces Axon FP – A Breakthrough Fiber-Delivered Femtosecond Laser for Multiphoton MicroscopySAXONBURG, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (
NYSE: COHR), a global leader in photonics, today announced the launch of the Axon FP, a new addition to the Axon family that redefines flexibility and accessibility in femtosecond laser technology.
Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent ActivityBOSTON and ATLANTA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension (“PAH”), today reported financial results for the quarter ended September 30, 2025 and highlighted recent developments.
NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational UpdateCALABASAS, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today announced financial results for the quarter ended September 30, 2025, and provided an update on recent operational achievements and upcoming milestones.
Femasys Announces Third Quarter Financial Results for 2025– FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval –
Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 MillionBRISBANE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced the closing of its previously announced underwritten public offering of 29,423,075 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 4,326,922 additional shares of common stock, at a price to the public of $2.60 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 3,750,000 shares of common stock at a purchase price of $2.599 per share, which equals the public offering price per share of the common stock less the $0.001 exercise price per share of each pre-funded warrant. The gross proceeds to Annexon from the offering were approximately $86.25 million, before deducting underwriting discounts and commissions and other offering expenses payable by Annexon.
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver InjurySilver Spring, Md., Nov. 14, 2025 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced it is taking action to approve new labeling submitted by the company that includes the addition of a Boxed Warning, the agency’s most prominent safety warning, to Elevidys (delandistrogene moxeparvovec-rokl), and that the indication section of the labeling limits the therapy’s indication to ambulatory patients four years of age and older with Duchenne muscular dystrophy (DMD). These actions follow reports of fatal acute liver failure in non-ambulatory patients treated with the product.
WeShop® Debuts on Nasdaq Under Ticker “WSHP”, Ushering in a New Retail RevolutionNEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- WeShop Holdings Limited (“WeShop” or the “Company”) (
NASDAQ: WSHP), the pioneering social-commerce platform allowing its users to earn ownership of the company through their shopping, announced that its Class A ordinary shares have begun trading on the Nasdaq Capital Market under the ticker symbol “WSHP.” The company plans to launch its app in the U.S. market, providing shoppers a seamless shopping experience along with the opportunity to create ownership. In the UK, WeShop already partners with major retailers such as John Lewis, eBay, Selfridges, ASOS, Expedia, British Airways, TEMU, Shein, and many more, offering access to thousands of brands and over 1.2 billion products. The company has completed over $140 million of sales in its UK pilot.
ThumbPRO® Baseball Thumb Guard Used by Players in the 2025 World SeriesCONCORD, MA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- ThumbPRO® Baseball Thumb Guard, a patented American-made protective device for hitters, has been identified as the thumb guard used by a few professional players in the 2025 World Series. The company confirmed the use of its product during the ongoing tournament, marking the 3rd appearance in 3 years of its thumb guard in professional-level competition.
UPDATE – Resolution Minerals Ltd. to Present at the Australian Rare Earths & Critical Minerals Virtual Investor Conference November 19thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
OROCO CLOSES FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENTVANCOUVER, Canada, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or “the Company”) is pleased to announce the closing of the second tranche of its non-brokered private placement, issuing an additional 2,500,000 units at a price of US$0.20 per unit, for gross proceeds of US$500,000.00. Each unit consists of one common share and one-half common share purchase warrant. Each whole warrant entitles the holder to purchase one share of the Company for US$0.30 for a period of 24 months from closing. Together with the first tranche, the Company has issued an aggregate of 10,154,995 units for gross proceeds of US$2,030,999.
Phaos Technology Announces Closing of Initial Public OfferingSINGAPORE, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“Phaos” or “the Company”), the investment holding company of Phaos Technology Pte. Ltd., an advanced microscopy solutions Company, today announced the closing of its previously announced initial public offering of an aggregate of 2,700,000 class A ordinary shares of the Company (the “Offering”) at a public offering price of US$4.00 per share (the “Offering Price”) to the public for a total of US$10,800,000 of gross proceeds to the Company, before deducting underwriting discounts and other offering expenses. Pursuant to the Offering, certain selling shareholders of the Company offered an aggregate of 900,090 class A ordinary shares of the Company at the Offering Price. The Company did not receive any proceeds from any sale of class A ordinary shares of the Company by those selling shareholders.
Latrobe Magnesium Limited to Present at the Australian Rare Earths & Critical Minerals Virtual Investor Conference November 19thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-QWARREN, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced the filing of its quarterly report on Form 10-Q for the quarter ended September 30, 2025, highlighting continued capital-efficient execution at a time when sustainability has become what the Company believes a defining challenge for the biotechnology industry.
Alussa Energy Acquisition Corp. II Announces Closing of $287,500,000 Initial Public OfferingNEW YORK, NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Alussa Energy Acquisition Corp. II (the “Company”) announced today that it consummated its initial public offering of 28,750,000 units at $10.00 per unit including the issuance of 3,750,000 units as a result of the underwriter’s full exercise of its over-allotment option. The offering resulted in gross proceeds to the Company of $287,500,000.
RockToken Enables Stable Crypto Investment Portfolios as Institutional Interest in Bitcoin SurgesInvestors focused on retirement and long-term income can now engage with infrastructure-backed digital asset contracts via RockToken.
Xcel Brands to Host Third Quarter 2025 Earnings Call on November 19, 2025NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (
NASDAQ: XELB) (“Xcel” or the “Company”), today announced that it will report its third quarter 2025 financial results on November 19, 2025. The Company will hold a conference call with the investment community on November 19, 2025, at 5:00 p.m. ET.
Newsweek and Plant-A Insights Recognize America’s Top Financial Advisory Firms for 2026NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Newsweek, in partnership with Plant-A Insights Group, announced today the 2026 ranking of America’s Top Financial Advisory Firms, recognizing 1,000 leading companies across the United States that are helping individuals and families achieve their financial goals with trust, transparency, and expertise.
SnapInspect Launches Property Inspection and Maintenance Software in AppFolio Stack™ Marketplace for Property ManagersTAMPA, Fla. and DURHAM, N.C., Nov. 14, 2025 (GLOBE NEWSWIRE) -- SnapInspect, a cloud-based inspection and maintenance solution, today announced its integration with AppFolio, the technology leader powering the future of the real estate industry. SnapInspect’s intuitive property inspection and maintenance software is now available in the AppFolio Stack™ Marketplace to provide a seamless and holistic experience for property managers.
Habit Burger & Grill Celebrates Lincoln Restaurant LaunchNew California Habit Restaurant to Open Doors on November 18Hold Pre-Opening VIP Events on November 15 and 17
Halper Sadeh LLC Encourages FRGE, BHF, GDEN Shareholders to Contact the Firm to Discuss Their RightsShareholders should contact the firm immediately as there may be limited time to enforce your rights
Halper Sadeh LLC Encourages THS and GIFI Shareholders to Contact the Firm to Discuss Their RightsShareholders should contact the firm immediately as there may be limited time to enforce your rights
Transaction in Own SharesTransaction in Own Shares
JCB Brings Big Support and Big Iron to VetsAid Charity Concert November 15Custom-painted machine to be unveiled as part of national fundraising partnership
Calian to Hold Conference Call Following Announcement of Fourth Quarter and FY 2025 ResultsOTTAWA, Ontario, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, will hold a conference call at 8:30 a.m. Eastern Time on Wednesday, November 26, 2025, to discuss results for the three-month and annual periods ended September 30, 2025. The results will be released before markets open.
THE BAHAMAS PARTNERS WITH MINDTRIP TO UNLOCK ONE-OF-A-KIND ADVENTURES THROUGH THE POWER OF AIFrom exploring its treasure trove of pink sand beaches to immersing oneself in the area’s vibrant culture, Mindtrip’s AI transforms The Bahamas’ 16 uniquely captivating and distinct islands into personalized travel recommendations for singles, couples, and families alike.
LCPC AI Announces Launch of New Blockchain Contract Program for XRPLCPC AI today announced the launch of its new blockchain contract program designed for the XRP ecosystem, marking a strategic step in the company’s ongoing commitment to advancing sustainable and transparent cryptocurrency technologies.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against CarMax, Inc. (NYSE: KMX)NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of CarMax, Inc. (“CarMax” or the “Company”) (
NYSE: KMX) between June 20, 2025 and November 5, 2025, inclusive.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Fiserv, Inc. (NYSE: FI)NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Fiserv, Inc. (“Fiserv” or the “Company”) (
NYSE: FI) between July 23, 2025 and October 29, 2025, inclusive.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against James Hardie Industries plc (NYSE: JHX)NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of James Hardie Industries plc (“James Hardie” or the “Company”) (
NYSE: JHX) between May 20, 2025 and August 18, 2025, inclusive.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Avantor, Inc. (NYSE: AVTR)NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Avantor, Inc. (“Avantor” or the “Company”) (
NYSE: AVTR) between March 5, 2024 and October 28, 2025, inclusive.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Synopsys, Inc. (NASDAQ: SNPS)NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Synopsys, Inc. (“Synopsys” or the “Company”) (
NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, inclusive.
KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (
NYSE: KMX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
